Kim, H., Liew, D., & Goodall, S. (2020). Cost‐effectiveness and financial risks associated with immune checkpoint inhibitor therapy. Br J Clin Pharmacol.
Citação norma ChicagoKim, Hansoo, Danny Liew, and Stephen Goodall. "Cost‐effectiveness and Financial Risks Associated With Immune Checkpoint Inhibitor Therapy." Br J Clin Pharmacol 2020.
Citação norma MLAKim, Hansoo, Danny Liew, and Stephen Goodall. "Cost‐effectiveness and Financial Risks Associated With Immune Checkpoint Inhibitor Therapy." Br J Clin Pharmacol 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.